[HTML][HTML] The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination

SR Parikh, H Campbell, JA Bettinger, LH Harrison… - Journal of Infection, 2020 - Elsevier
Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide
and is associated with high case fatality rates and serious life-long complications among …

Immunoinformatics and vaccine development: an overview

AN Oli, WO Obialor, MO Ifeanyichukwu… - ImmunoTargets and …, 2020 - Taylor & Francis
The use of vaccines have resulted in a remarkable improvement in global health. It has
saved several lives, reduced treatment costs and raised the quality of animal and human …

[HTML][HTML] The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines

SI Pelton - Journal of Adolescent Health, 2016 - Elsevier
Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is associated with
high morbidity and mortality. Although IMD incidence is highest in infants, a second peak …

Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India

Z Du, L Wang, A Pandey, WW Lim, M Chinazzi… - Nature Medicine, 2022 - nature.com
Abstract Given global Coronavirus Disease 2019 (COVID-19) vaccine shortages and
inequity of vaccine distributions, fractionation of vaccine doses might be an effective strategy …

Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and …

M McMillan, A Chandrakumar… - Clinical Infectious …, 2021 - academic.oup.com
Background Invasive meningococcal disease (IMD), caused by Neisseria meningitidis,
leads to significant morbidity and mortality worldwide. This review aimed to establish the …

[HTML][HTML] Meningococcal disease, a clinical and epidemiological review

RS Batista, AP Gomes, JLD Gazineo… - Asian Pacific journal of …, 2017 - Elsevier
Meningococcal disease is the acute infection caused by Neisseria meningitidis, which has
humans as the only natural host. The disease is widespread around the globe and is known …

[HTML][HTML] Deciphering the burden of meningococcal disease: conventional and under-recognized elements

F Martinón-Torres - Journal of Adolescent Health, 2016 - Elsevier
Invasive meningococcal disease remains a substantial global public health burden despite
being vaccine-preventable worldwide. More than one million cases are reported annually …

[HTML][HTML] Meningococcal disease in North America: updates from the global meningococcal initiative

EJ Asturias, X Bai, JA Bettinger, R Borrow, DN Castillo… - Journal of Infection, 2022 - Elsevier
This review summarizes the recent Global Meningococcal Initiative (GMI) regional meeting,
which explored meningococcal disease in North America. Invasive meningococcal disease …

[HTML][HTML] Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation

C Brehony, CMC Rodrigues, R Borrow, A Smith… - Vaccine, 2016 - Elsevier
Serogroup B is the only major disease-associated capsular group of Neisseria meningitidis
for which no protein-polysaccharide conjugate vaccine is available. This has led to the …

Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination

C Burman, L Serra, C Nuttens, J Presa… - Human vaccines & …, 2019 - Taylor & Francis
Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is characterized by
high mortality and morbidity. While IMD incidence peaks in both infants and …